Transformational deal making: Oxford Biomedica
Given the recent announcement of Oxford Biomedica securing £50m loan fundin...
Read More
Given the recent announcement of Oxford Biomedica securing £50m loan fundin...
Read MoreDr John Beadle, CEO of PsiOxus Therapeutics outlines what the investment wi...
Read MoreProf. Gary Ford CBE, talks through what OAHSN is doing to break down tradit...
Read More3 months into his tenure as CEO of NetScientific, the vastly experienced in...
Read MoreFresh from their record breaking £205m private finance raising, we talk to ...
Read MoreNewly appointed Chairman and CEO, Chris Yates discusses the potential of Ab...
Read MoreWe talk to CEO David Venables off the back of Synpromics securing £2.1m EIS...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read More
Add Your Response